Mehadrin

Mehadrin EBIT per Share

The EBIT per Share of Mehadrin (MEDN.TA) as of Oct 5, 2026 is 5.44 ILS. In the previous year, EBIT per Share was -18.86 ILS — a change of -128.84% (higher).

EBIT per Share

5.44ILS

YoY

-128.84%

Last updated:

EBIT per Share of Mehadrin is 2026 5.44 ILS. EBIT per Share of Mehadrin was 2025 -18.86 ILS. It decreases by -128.84% higher compared to the previous year.

The Mehadrin EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
16.97 ILS
Jan 1, 2019
11.12 ILS
Jan 1, 2020
5.97 ILS
Jan 1, 2021
56.49 ILS
Jan 1, 2022
-24.16 ILS
Jan 1, 2023
-44.68 ILS
Jan 1, 2024
-18.86 ILS
Jan 1, 2025
5.44 ILS
The Mehadrin EBIT per Share history
YEAREBIT per ShareYoY
5.44ILS-128.84%
-18.86ILS-57.80%
-44.68ILS+84.97%
-24.16ILS-142.76%
56.49ILS+846.15%
5.97ILS-46.29%
11.12ILS-34.49%
16.97ILS-32.20%
25.03ILS+121.77%
11.28ILS+37.74%
8.19ILS+224.10%
2.53ILS-74.83%
10.04ILS-39.43%
16.58ILS+10.57%
15.00ILS-25.45%
20.12ILS+35.48%
14.85ILS+42.31%
10.43ILS-60.97%
26.73ILS+185.48%
9.36ILS—
Access this data via the Eulerpool API

Mehadrin Stock analysis

What does Mehadrin do? Mehadrin Ltd is a leading company in the agricultural and fruit industry based in Israel. It was founded in 1936 and has since become a global player, operating in over 35 countries and producing and distributing fruits and vegetables of the highest quality. Mehadrin is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mehadrin stock

EBIT per Share of Mehadrin is 5.44 ILS in 2026.

EBIT per Share of Mehadrin changed from -18.86 ILS to 5.44 ILS, representing a -128.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Mehadrin since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

Income Statement — Mehadrin

All Key Metrics — Mehadrin